Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04704323 |
Title | CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Catapult Therapeutics |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ESP |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Dana-Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
Duke University | RECRUITING | Durham | North Carolina | 27705 | United States | Details |
Ohio State University | ACTIVE_NOT_RECRUITING | Columbus | Ohio | 43210 | United States | Details |
Hospital Universitario de La Princesa | NOT_YET_RECRUITING | Madrid | 28006 | Spain | Details | |
Hospital Universitario de Santiago de Compostela | NOT_YET_RECRUITING | Madrid | 28040 | Spain | Details | |
Hospital Universitario Marqués de Valdecilla | NOT_YET_RECRUITING | Santander | 39008 | Spain | Details |